[1]方吕贵,饶向荣,李深,等.缓衰口服液对动脉粥样硬化性肾动脉狭窄小鼠肾脏低氧-微血管荒废-肾间质纤维化的影响[J].中国中医药信息杂志,2015,22(1):53-57.[doi:10.3969/j.issn.1005-5304.2015.01.016]
 FANG Lv-gui,RAO Xiang-rong,LI Shen,et al.Effects of Huanshuai Oral Liquid in the Process of Hypoxia-Microvascular Waste-Renal Interstitial Fibrosis in Mice with Atherosclerosis Renal Artery Stenosis[J].zhongguo zhongyiyao xinxi zazhi,2015,22(1):53-57.[doi:10.3969/j.issn.1005-5304.2015.01.016]
点击复制

缓衰口服液对动脉粥样硬化性肾动脉狭窄小鼠肾脏低氧-微血管荒废-肾间质纤维化的影响

参考文献/References:

[1] Orphanides C, Norman JT. Progressive renal disease:the chronic hypoxia hypothesis[J]. Kidney Int Suppl,1998,65:S74-78.

[2] Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal disease other than proteinuria? Towards the unifying theme of chronic hypoxia[J]. Kidney Int Suppl,2000,75:S22-26.

[3] Nangaku M, Inagi R, Miyata T, et al. Hypoxia and hypoxia- inducible factor in renal disease[J]. Nephron Exp Nephrol,2008, 110(1):e2-e7.

[4] Neilson EG. Mechanisms of diseaseFibroblasts- a new look at an old problem[J]. Nat Clin Pract Nephrol,2006,2(2):101-108.

[5] Suguru Yamamoto, Yiqin Zuo, Ji Ma, et al. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice[J]. Nephrol Dial Transplant,2011,29:1-7.

[6] Chunsong Cheng, Daiyin Peng, Luqi Huang, et al. Years- identification mathematical model of Paeonia lactiflora Pall. Based on the allometric-scaling[J]. Microscopy Research and Technique,2013,76:201-208.

[7] Zhu X, Rodriguez-Porcel M, Bentley MD, et al. Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia[J]. Circulation,2004,109:2109-2115.

[8] Knouf C, Hinsdale ME, Mezdour H, et al. ApoE structure determines VLDL clearance and atherosclerosis risk in mice[J]. Jain Invest, 1999,103(11):1579-1586.

[9] 黄朝晖,吴雄飞,赵洪雯,等.ApoE-/-小鼠肾动脉狭窄及肾损害特点观察[J].第三军医大学学报,2007,29(19):1844-1847.

[10] Carmine Zoccali. Endothelial dysfunction in CKD:a new player in town?[J]. Nephrol Dial Transplant,2008,23(3):783-785.

[11] 饶向荣,张南南,李深,等.动脉粥样硬化性肾动脉狭窄中医证候初探[J].中国中西医结合肾病杂志,2010,11(2):125-127.

[12] 李雪霞,饶向荣.动脉粥样硬化肾动脉狭窄证治初探[J].中国中医药信息杂志,2009,16(2):90-91.

[13] Rao XR, Li S, Dai XW, et al. Effect of Huanshuai Recipe (缓衰方) on expression of extr acellular matr ix in 5/6 nephrectomized rats[J]. CJIM,2000,6(4):295-298.

[14] The ASTRAL Investigators. Revascularization versus medical therapy for renal-artery stenosis[J]. NEJM,2009,361(12):1953- 1962.

[15] Thomas A. After ASTRAL and STAR-Whither renal artery stenting[J]. Interventional Medicine & Applied Science,2010, 2(4)153-158.

[16] Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomerulopathies:a review from the interstitium[J]. Exp Nephrol,1994,2(4):205-210.

[17] Kimura K, Iwano M, Higgins DF, et al. Stable expression of HIF-1αin tubular epithelial cells promotes interstitial fibrosis[J]. Am J Physiol Renal Physiol,2008,295(4):F1023-F1029.

[18] Nangaku M. Chronic hypoxia and tubulointerstitial injury:a final common pathway to end-stage renal failure[J]. J Am Soc Nephrol,2006,17:17-25.

[19] 李深,饶向荣,李晓枚,等.缓衰方对肾大部切除大鼠肾内微血管重塑的影响[J].中国中西医结合肾病杂志,2008,9(10):867-870.

[20] Martinez AW, Recht NS, Hostetter TH, et al. Removal of P-cresol sulfate by hemodialysis[J]. J Am Soc Nephro,2005,16:3430-3436.

备注/Memo

基金项目:国家自然科学基金(81141122)

更新日期/Last Update:

2014-12-16